Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.56 - $16.15 $366,077 - $782,031
48,423 New
48,423 $752,000
Q3 2023

Nov 14, 2023

BUY
$7.0 - $11.26 $119,266 - $191,847
17,038 New
17,038 $119,000
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $377,753 - $696,136
-34,720 Reduced 96.48%
1,267 $14,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $577,951 - $949,696
35,987 New
35,987 $612,000
Q1 2022

May 16, 2022

SELL
$28.19 - $46.6 $8.09 Million - $13.4 Million
-287,029 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $1.01 Million - $1.81 Million
24,582 Added 9.37%
287,029 $13.1 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $656,150 - $1.02 Million
11,093 Added 4.41%
262,447 $16.6 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $8.36 Million - $12.6 Million
-132,610 Reduced 34.54%
251,354 $23 Million
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $8.59 Million - $14.2 Million
148,999 Added 63.41%
383,964 $26.1 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $5.59 Million - $10.4 Million
-134,846 Reduced 36.46%
234,965 $17 Million
Q3 2020

Nov 16, 2020

BUY
$30.88 - $37.94 $8.59 Million - $10.6 Million
278,290 Added 304.07%
369,811 $14 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $2.71 Million - $5.07 Million
-143,191 Reduced 61.01%
91,521 $3.24 Million
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $2.18 Million - $4.42 Million
-156,627 Reduced 40.02%
234,712 $5.12 Million
Q4 2019

Feb 14, 2020

BUY
$19.24 - $28.41 $7.53 Million - $11.1 Million
391,339 New
391,339 $8.44 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $256,124 - $395,114
-9,935 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$22.09 - $39.21 $219,464 - $389,551
9,935 New
9,935 $313,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.